These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 9675364

  • 1. Synthesis and antitumor activity of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) daunomycinone derivatives modified at C-3' or C-4'.
    Takagi Y, Kobayashi N, Chang MS, Lim GJ, Tsuchiya T.
    Carbohydr Res; 1998 Feb; 307(3-4):217-32. PubMed ID: 9675364
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-alpha-L-talopyranosyl]- daunomycinone and -adriamycinone.
    Nakai K, Takagi Y, Tsuchiya T.
    Carbohydr Res; 1999 Mar 31; 316(1-4):47-57. PubMed ID: 10420587
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of antitumor-active 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Ok K, Takagi Y, Tsuchiya T, Umezawa S, Umezawa H.
    Carbohydr Res; 1987 Nov 15; 169():69-81. PubMed ID: 3427590
    [Abstract] [Full Text] [Related]

  • 4. Syntheses and antitumor activities of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Tsuchiya T, Takagi Y, Ok K, Umezawa S, Takeuchi T, Wako N, Umezawa H.
    J Antibiot (Tokyo); 1986 May 15; 39(5):731-3. PubMed ID: 3733524
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis of 7-O-[2,6-dideoxy-2-fluoro-4-O-(3-fluorotetrahydropyran-2-yl)- alpha-L-talopyranosyl]daunomycinone.
    Takagi Y, Sohtome H, Tsuchiya T, Umezawa S, Takeuchi T.
    J Antibiot (Tokyo); 1992 Mar 15; 45(3):355-62. PubMed ID: 1577663
    [Abstract] [Full Text] [Related]

  • 6. Syntheses and antitumor activities of 7-O-(6-deoxy-2-O-methyl-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Takagi Y, Kobayashi N, Tsuchiya T, Umezawa S, Takeuchi T, Komuro K, Nosaka C.
    J Antibiot (Tokyo); 1989 Aug 15; 42(8):1318-20. PubMed ID: 2759915
    [No Abstract] [Full Text] [Related]

  • 7. Inhibitory activity of four demethoxy fluorinated anthracycline analogs against five human-tumor cell lines.
    Horton D, Khare A.
    Bioorg Med Chem Lett; 2010 Nov 01; 20(21):6179-81. PubMed ID: 20850305
    [Abstract] [Full Text] [Related]

  • 8. [14-O-hemiesters and 13-hydrazones of anthracyline antibiotics of the daunorubicin series. Synthesis and cytostatic activity with respect to tumor cells sensitive or resistant to doxorubicin].
    Povarov LS, Leont'eva OV, Bernaki PD, Olsuf'eva EN, Salimova EI, Pera P, Preobrazhenskaia MN.
    Bioorg Khim; 1995 Dec 01; 21(12):925-32. PubMed ID: 8602889
    [Abstract] [Full Text] [Related]

  • 9. Syntheses and antitumor activities of 7-O-(3-amino-2,3,6-trideoxy-2-fluoro-alpha-L-talopyranosyl)daunomvcinone and -adriamycinone.
    Takagi Y, Park H, Tsuchiya T, Umezawa S, Takeuchi T, Komuro K, Nosaka C.
    J Antibiot (Tokyo); 1989 Aug 01; 42(8):1315-7. PubMed ID: 2759914
    [No Abstract] [Full Text] [Related]

  • 10. Design, synthesis and biological activity of 7-O-(4-O-acetyl-3-iodo-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl) daunomycinone and 7-O-(3-chloro-2,3,6-trideoxy-4-O-propanoyl-alpha-L-lyxo- hexopyranosyl)daunomycinone.
    Aligiannis N, Pouli N, Marakos P, Mitaku S, Skaltsounis AL, Leonce S, Pierre A, Atassi G.
    Chem Pharm Bull (Tokyo); 2000 Jan 01; 48(1):150-3. PubMed ID: 10705494
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
    Stefańska B, Dzieduszycka M, Bontemps-Gracz M, Borowski E, Martelli S.
    J Antibiot (Tokyo); 1988 Feb 01; 41(2):193-8. PubMed ID: 3356607
    [Abstract] [Full Text] [Related]

  • 12. Adriamycin analogues. Preparation and antitumor evaluation of 7-O-(beta-D-glucosaminyl)daunomycinone and 7-O-(beta-D-glucosaminyl)adriamycinone and their N-trifluoroacetyl derivatives.
    Israel M, Murray RJ.
    J Med Chem; 1982 Jan 01; 25(1):24-8. PubMed ID: 7086817
    [Abstract] [Full Text] [Related]

  • 13. Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy.
    Florent JC, Dong X, Gaudel G, Mitaku S, Monneret C, Gesson JP, Jacquesy JC, Mondon M, Renoux B, Andrianomenjanahary S, Michel S, Koch M, Tillequin F, Gerken M, Czech J, Straub R, Bosslet K.
    J Med Chem; 1998 Sep 10; 41(19):3572-81. PubMed ID: 9733483
    [Abstract] [Full Text] [Related]

  • 14. 3'-Hydroxyesorubicin. Synthesis and antitumor activity.
    Priebe W, Neamati N, Perez-Soler R.
    J Antibiot (Tokyo); 1990 Jul 10; 43(7):838-46. PubMed ID: 2387778
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, biological and biochemical properties of new anthracyclines modified in the aminosugar moiety.
    Bargiotti A, Casazza AM, Cassinelli G, Di Marco A, Penco S, Pratesi G, Supino R, Zaccara A, Zunino F, Arcamone F.
    Cancer Chemother Pharmacol; 1983 Jul 10; 10(2):84-9. PubMed ID: 6831630
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and antitumor activity of 5'-demethyl-5'-trifluoromethyl-daunorubicin and -doxorubicin.
    Nakai K, Takagi Y, Ogawa S, Tsuchiya T.
    Carbohydr Res; 1999 Jul 20; 320(1-2):8-18. PubMed ID: 10515060
    [Abstract] [Full Text] [Related]

  • 17. 3'-Hydroxyesorubicin halogenated at C-2'.
    Priebe W, Neamati N, Perez-soler R.
    J Antibiot (Tokyo); 1992 Mar 20; 45(3):386-93. PubMed ID: 1577666
    [Abstract] [Full Text] [Related]

  • 18. [Anthracycline antibiotics and their derivatives--inhibitors of topoisomerase I].
    Dezhenkova LG, Teviashova AN, Olsuf'eva EN, Treshchalin ID, Shtil' AA, Preobrazhenskaia MN.
    Bioorg Khim; 2008 Mar 20; 34(3):430-2. PubMed ID: 18672696
    [Abstract] [Full Text] [Related]

  • 19. Anthracycline glycosides of 2,6-dideoxy-2-fluoro-alpha-L-talopyranose.
    Horton D, Khare A.
    Carbohydr Res; 2006 Nov 27; 341(16):2631-40. PubMed ID: 17022957
    [Abstract] [Full Text] [Related]

  • 20. Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin.
    Mosher CW, Wu HY, Fujiwara AN, Acton EM.
    J Med Chem; 1982 Jan 27; 25(1):18-24. PubMed ID: 7086816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.